🚀 VC round data is live in beta, check it out!
- Public Comps
- Biomind Labs
Biomind Labs Valuation Multiples
Discover revenue and EBITDA valuation multiples for Biomind Labs and similar public comparables like Aton, ExpreS2ion Biotech, Pila Pharma, Vivesto and more.
Biomind Labs Overview
About Biomind Labs
Biomind Labs Inc is a biotech research and development company aimed at transforming biomedical sciences knowledge from natural psychotropic plants into novel pharmaceutical drugs and nanotech delivery systems for a variety of psychiatric and neurological conditions. Biomind is developing pharmaceutical sole and combined formulations of the main natural psychedelic molecules with the objective of identifying novel pharmaceutical compounds for treating a wide range of therapeutic indications.
Founded
2020
HQ

Employees
3
Website
Sectors
Financials (FY)
EV
$7M
Biomind Labs Financials
Biomind Labs reported last fiscal year revenue of — and negative EBITDA of ($219K).
In the same fiscal year, Biomind Labs generated ($219K) in EBITDA losses and had net loss of ($260K).
Biomind Labs P&L
In the most recent fiscal year, Biomind Labs reported revenue of — and EBITDA of ($219K).
Biomind Labs expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| EBITDA | — | XXX | ($219K) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($260K) | XXX | XXX | XXX |
| Net Debt | — | — | $671K | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Biomind Labs Stock Performance
Biomind Labs has current market cap of $6M, and enterprise value of $7M.
Biomind Labs' stock price is $0.08.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $7M | $6M | -0.3% | XXX | XXX | XXX | $-0.00 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialBiomind Labs Valuation Multiples
Biomind Labs trades at (29.8x) EV/EBITDA.
Biomind Labs Financial Valuation Multiples
As of March 28, 2026, Biomind Labs has market cap of $6M and EV of $7M.
Equity research analysts estimate Biomind Labs' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Biomind Labs has a P/E ratio of (22.6x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $6M | XXX | $6M | XXX | XXX | XXX |
| EV (current) | $7M | XXX | $7M | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (29.8x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (16.1x) | XXX | XXX | XXX |
| P/E | — | XXX | (22.6x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (18.4x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Biomind Labs Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Biomind Labs Margins & Growth Rates
Biomind Labs' revenue in the last fiscal year grew by —.
Biomind Labs Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| EBITDA Growth | — | XXX | (79%) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Biomind Labs Public Comps
See public comps and valuation multiples for other Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Aton | XXX | XXX | XXX | XXX | XXX | XXX |
| ExpreS2ion Biotech | XXX | XXX | XXX | XXX | XXX | XXX |
| Pila Pharma | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivesto | XXX | XXX | XXX | XXX | XXX | XXX |
| Genxone | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Biomind Labs M&A Activity
Biomind Labs acquired XXX companies to date.
Last acquisition by Biomind Labs was on XXXXXXXX, XXXXX. Biomind Labs acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Biomind Labs
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialBiomind Labs Investment Activity
Biomind Labs invested in XXX companies to date.
Biomind Labs made its latest investment on XXXXXXXX, XXXXX. Biomind Labs invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Biomind Labs
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Biomind Labs
| When was Biomind Labs founded? | Biomind Labs was founded in 2020. |
| Where is Biomind Labs headquartered? | Biomind Labs is headquartered in Uruguay. |
| How many employees does Biomind Labs have? | As of today, Biomind Labs has over 3 employees. |
| Is Biomind Labs publicly listed? | Yes, Biomind Labs is a public company listed on NEO Exchange. |
| What is the stock symbol of Biomind Labs? | Biomind Labs trades under BMND ticker. |
| When did Biomind Labs go public? | Biomind Labs went public in 2021. |
| Who are competitors of Biomind Labs? | Biomind Labs main competitors are Aton, ExpreS2ion Biotech, Pila Pharma, Vivesto. |
| What is the current market cap of Biomind Labs? | Biomind Labs' current market cap is $6M. |
| Is Biomind Labs profitable? | No, Biomind Labs is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.